Akron Children's > For Families & Patients > Research > Pediatric Clinical Studies > Open Clinical Studies
Safety and effectiveness of oxybutynin in children (6-16 years) with neurogenic bladder
Full IRB Study Title:
A Multi-Center, Double-Blind, Placebo-Controlled, Dose-Titration Study Evaluating the Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of Oxybutynin Chloride Topical Gel for the Treatment of Detrusor Overactivity Associated with a Neurological Condition in Pediatric Subjects
IRB Study ID: 110208
Who May Qualify:
Patients 6-16 years old with neurogenic detrusor overactivity
Who Does NOT Qualify:
Patients who are pregnant, involved in other investigational studies or have certain medical conditions
Lead Investigator
Daniel McMahon, MD
Director, Pediatric Urology; Pediatric Urologist
Pediatric UrologyKidney Stone Clinic
